Probing the interface between factor Xa and tissue factor in the quaternary complex tissue factor-factor VIIa-factor Xa-tissue factor pathway inhibitor

被引:22
作者
Carlsson, K [1 ]
Freskgård, PO
Persson, E
Carlsson, U
Svensson, M
机构
[1] Linkoping Univ, IFM, Dept Chem, SE-58183 Linkoping, Sweden
[2] Novo Nordisk AS, Prot Biotechnol, DK-2880 Bagsvaerd, Denmark
[3] Novo Nordisk AS, Haemostasis Biol, Malov, Denmark
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2003年 / 270卷 / 12期
关键词
fluorescence; local probing; protein-protein interactions; site-directed labeling;
D O I
10.1046/j.1432-1033.2003.03625.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Blood coagulation is triggered by the formation of a complex between factor VIIa (FVIIa) and its cofactor, tissue factor (TF). TF-FVIIa is inhibited by tissue factor pathway inhibitor (TFPI) in two steps: first TFPI is bound to the active site of factor Xa (FXa), and subsequently FXa-TFPI exerts feedback inhibition of TF-FVIIa. The FXa-dependent inhibition of TF-FVIIa activity by TFPI leads to formation of the quaternary complex TF-FVIIa-FXa-TFPI. We used site-directed fluorescence probing to map part of the region of soluble TF (sTF) that interacts with FXa in sTF-FVIIa-FXa-TFPI. We found that the C-terminal region of sTF, including positions 163, 166, 200 and 201, is involved in binding to FXa in the complex, and FXa, most likely via its Gla domain, is also in contact with the Gla domain of FVIIa in this part of the binding region. Furthermore, a region that includes the N-terminal part of the TF2 domain and the C-terminal part of the TF1 domain, i.e. the residues 104 and 197, participates in the interaction with FXa in the quaternary complex. Moreover, comparisons of the interaction areas between sTF and FX(a) in the quaternary complex sTF-FVIIa-FXa-TFPI and in the ternary complexes sTF-FVII-FXa or sTF-FVIIa-FX demonstrated large similarities.
引用
收藏
页码:2576 / 2582
页数:7
相关论文
共 37 条
[1]   The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor [J].
Banner, DW ;
DArcy, A ;
Chene, C ;
Winkler, FK ;
Guha, A ;
Konigsberg, WH ;
Nemerson, Y ;
Kirchhofer, D .
NATURE, 1996, 380 (6569) :41-46
[2]   Exosite interactions determine the affinity of factor X for the extrinsic Xase complex [J].
Baugh, RJ ;
Dickinson, CD ;
Ruf, W ;
Krishnaswamy, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (37) :28826-28833
[3]   X-ray structure of active site-inhibited clotting factor Xa - Implications for drug design and substrate recognition [J].
Brandstetter, H ;
Kuhne, A ;
Bode, W ;
Huber, R ;
vonderSaal, W ;
Wirthensohn, K ;
Engh, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (47) :29988-29992
[4]   REGULATION OF COAGULATION BY A MULTIVALENT KUNITZ-TYPE INHIBITOR [J].
BROZE, GJ ;
GIRARD, TJ ;
NOVOTNY, WF .
BIOCHEMISTRY, 1990, 29 (33) :7539-7546
[5]   Influence of mutations in tissue factor on the fine specificity of macromolecular substrate activation [J].
Dittmar, S ;
Ruf, W ;
Edgington, TS .
BIOCHEMICAL JOURNAL, 1997, 321 :787-793
[6]   Structural changes in factor VIIa induced by Ca2+ and tissue factor studied using circular dichroism spectroscopy [J].
Freskgard, PO ;
Olsen, OH ;
Persson, E .
PROTEIN SCIENCE, 1996, 5 (08) :1531-1540
[7]   CALCULATION OF PROTEIN EXTINCTION COEFFICIENTS FROM AMINO-ACID SEQUENCE DATA [J].
GILL, SC ;
VONHIPPEL, PH .
ANALYTICAL BIOCHEMISTRY, 1989, 182 (02) :319-326
[8]   FUNCTIONAL-SIGNIFICANCE OF THE KUNITZ-TYPE INHIBITORY DOMAINS OF LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR [J].
GIRARD, TJ ;
WARREN, LA ;
NOVOTNY, WF ;
LIKERT, KM ;
BROWN, SG ;
MILETICH, JP ;
BROZE, GJ .
NATURE, 1989, 338 (6215) :518-520
[9]   INHIBITION OF FACTOR-VIIA TISSUE FACTOR COAGULATION ACTIVITY BY A HYBRID PROTEIN [J].
GIRARD, TJ ;
MACPHAIL, LA ;
LIKERT, KM ;
NOVOTNY, WF ;
MILETICH, JP ;
BROZE, GJ .
SCIENCE, 1990, 248 (4961) :1421-1424
[10]   The inhibitors of the tissue factor:factor VII pathway [J].
Golino, P .
THROMBOSIS RESEARCH, 2002, 106 (03) :V257-V265